Decoy Therapeutics Inc.
DCOY· Nasdaq
DCOYDecoy Therapeutics Inc.
Filed Aug 5, 2015 · 10-Q · 36 days after period end · 0001615219-15-000039
| Metric | Q2 2015 | Q2 2014 |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | -$7.08M | -$2.19M |
| EPS Diluted | -$0.47 | -$1.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 5, 2015 · 36 d after period end
